Importance of oxidative polymorphism on clinical efficacy and side-effects of imipramine--a retrospective study.
Meyer
J W
JW
Research Department, Psychiatric University Hospital Zürich, Switzerland.
Woggon
B
B
Küpfer
A
A
D003647:Debrisoquin / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D003866:Depressive Disorder / Q000188:drug therapy / Q000523:psychology; D005260:Female; D006801:Humans; D007099:Imipramine / Q000009:adverse effects / Q000378:metabolism* / Q000627:therapeutic use; D008297:Male; D008617:Mephenytoin / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D008875:Middle Aged; D010084:Oxidation-Reduction
D007099:Imipramine; D008617:Mephenytoin; D003647:Debrisoquin